Latest Updates & News
FDA Approves Velsipity for Ulcerative Colitis Treatment on October 13, 2023
What is Velsipity prescribed for? Velsipity is prescribed to treat moderately to severely active ulcerative colitis in adults. What is the name of the drug and what does it do? Velsipity, pronounced Vel-sip-itee, (generic name: etrasimod) is a new medication approved by the FDA to treat adults with moderately to severely active ulcerative colitis, a form of...
FDA Approves Rivfloza for Late-Onset Pompe Disease on September 28, 2023
What is Rivfloza prescribed for? Rivfloza is used to treat Late-Onset Pompe Disease, a rare condition where the body can't break down sugar properly due to a missing enzyme. This causes sugar to build up in the muscles, leading to muscle weakness and breathing problems. Rivfloza helps by replacing the missing enzyme, making it easier for the body to...
FDA Approves DAYBUE for Treating Rett Syndrome Symptoms on March 10, 2023
What is DAYBUE prescribed for? DAYBUE (generic name: trofinetide), pronounced “day-BYOO,” is indicated for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older. What is the name of the drug and what does it do? DAYBUE is used to treat Rett syndrome in adults and children who are 2 years old or older. Rett...
FDA Approves ZAVZPRET Nasal Spray for Rapid Relief of Acute Migraine Symptoms on March 2023
What is ZAVZPRET prescribed for? ZAVZPRET is prescribed for the acute treatment of migraine with or without aura in adults. What is the name of the drug and what does it do? Zavzpret (generic name: zavegepant), pronounced “zav-spret,” is a medication for adults suffering from migraine headaches, with or without a warning sensation (aura)...
FDA Approves SKYCLARYS to Aid Friedreich’s Ataxia Patients on February 28, 2023
What is SKYCLARYS prescribed for? SKYCLARYS is prescribed for the treatment of Friedreich’s ataxia in adults and adolescents aged 16 years and older. What is the name of the drug and what does it do? SKYCLARYS is a medication for adults and teenagers aged 16 years and above who have Friedreich’s ataxia (FA). FA is a rare genetic...
FDA Approves FILSPARI to Aid Kidney Health in IgA Nephropathy on February 2023
What is FILSPARI prescribed for? FILSPARI is prescribed to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression. What is the name of the drug and what does it do? FILSPARI (generic name: sparsentan), pronounced “fil spah’ ree,” is a medicine that helps adults with a kidney condition called...